28 ■ Cancer Nursing™, Vol. 25, No. 1, 2002 Weinrich et al Interest in Genetic Prostate Cancer Susceptibility Testing Among African American Men Six regions for prostate cancer genes have been identified, and it is anticipated that prostate cancer susceptibility testing will be available in the future. This corre- lational study identified predictors for interest in prostate cancer susceptibility test- ing among African American men. Participants were 320 African American men from the African American Hereditary Prostate Cancer Study and the South Car- olina Prostate Cancer Education and Screening Study participated. Two questions measured interest in genetic prostate cancer susceptibility testing and family his- tory of prostate cancer. Chi-square analyses by family history as well as demo- graphics (age, education, marital status) were performed. Most of the men (277 [87%]) indicated an interest in genetic prostate cancer susceptibility testing. Interest in undergoing testing did not vary by family his- tory, age, or education. Marital status was the only significant demographic predictor. Men who were married were significantly more likely to respond with a “yes” to interest in prostate cancer susceptibility testing than were men who were not married. The high “yes” response rate and the men’s confusion between the genetic prostate cancer susceptibility testing and prostate cancer screening highlight the need for public education once prostate cancer genes are identified and available for public testing. © 2002 Lippincott Williams & Wilkins, Inc., Philadelphia Sally Weinrich, PhD, RN, FAAN Charmaine Royal, PhD Curtis A. Pettaway, MD Georgia Dunston, PhD Louise Faison-Smith, AD Julie Hudson Priest, MSPH Pamela Roberson-Smith, AS Jacqueline Frost, DMS Jean Jenkins, PhD, RN, FAAN Karen Albiez Brooks, MS, CGC Isaac Powell, MD From the University of Louisville, Ky (Dr Weinrich); South Carolina Can- cer Center, University of South Carolina, Columbia (Dr Weinrich and Ms Fai- son-Smith); National Human Genome Center at Howard University, Wash- ington, DC (Dr Royal); M.D. Anderson Cancer Center, Houston, Tex (Drs Pettaway and Frost and Ms Roberson-Smith); Howard University College of Medicine, Washington, DC (Dr Dunston); University of South Carolina, Columbia (Ms Priest); National Cancer Institute at the National Naval Med- ical Center, Bethesda, Md (Dr Jenkins); Genetic Center, School of Medicine, University of South Carolina, Columbia, SC (Ms Brooks); and Wayne State University, Detroit, Mich (Dr Powell). Corresponding author: Sally P. Weinrich, PhD, RN, School of Nursing, University of Louisville, KY 40292 (e-mail: sally.weinrich@louisville.edu). Accepted for publication October 10, 2001.